SOURCE-LINKED INTELLIGENCE

Iktos Robotics: Integrating AI and Robotics for efficient Drug Design and Discovery

CORDIS · observation · Publication date unknown

ency underscores the urgent need for innovation in drug discovery methodologies. Iktos proposes a transformative approach with its closed-loop AI-guided autonomous drug discovery platform, leveraging generative AI and built-in synthetic accessibility. This paradigm shift addresses key challenges in traditional drug discovery, including the generation of truly novel molecules, the speed of synthesis, and the management of high-dimensional data. Central to Iktos' solution are advanced SaaS platforms such as Makya and Spaya, powered by AI for rapid exploration of vast chemical spaces and efficient synthesis route planning. In this EIC Accelerator project, we want to combine AI and robotics to form a closed-loop, data-informed discovery platform, integrating AI-driven automated synthesis and testing into our workflow. Combined together these technologies enable the in silico design of optimal molecules and their corresponding synthesis in the lab to generate real-life data, accelerating the drug discovery timeline from an average of 5 years to just 2 years. Iktos' innovative approach le

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

2499616

unit

EUR